Pharmacokinetics of azithromycin as measured by HPLC-MS in health volunteers
Yan Dong
Abstract
Yan Dong
Abstract
Objective: To develop a HPLC-MS method for determining azithromycin in human plasma,and to investigate pharmacokinetics of azithromycin in healthy volunteers.Methods: In 18 healthy male volunteers,a single crossover oral dose of the test and reference azithromycin tablets(500 mg) were randomly administered.Azithromycin concentrations in plasma samples were determined by HPLC-MS after taking the drug.Results: The calibration curve of azithromycin concentration was linear in the range from 10 to 1 000 μg·L-1.The intra-day and inter-day RSD was less than 10%.The main pharmacokinetic parameters of the test and reference azithromycin tablets were as follows: Cmax(594.9±195.7) vs.(586.3±186.5) μg·L-1;Tmax(2.02±0.91) vs.(1.70 ± 0.80) h;T1/2(29.20±8.38) vs.(27.28±7.62) h;AUC0~t(4 736±1 317) vs.(4 567±1 129) μg·h·L-1.The relative bioavalability of test tablets was(104.0±14.6) %.Conclusion: HPLC-MS method established in this study is simpler and more sensitive with better accuracy,which is adapted to study azithromycin pharmacokinetics.The two preparations of azithromycin are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To develop a HPLC-MS method for determining azithromycin in human plasma,and to investigate pharmacokinetics of azithromycin in healthy volunteers.Methods: In 18 healthy male volunteers,a single crossover oral dose of the test and reference azithromycin tablets(500 mg) were randomly administered.Azithromycin concentrations in plasma samples were determined by HPLC-MS after taking the drug.Results: The calibration curve of azithromycin concentration was linear in the range from 10 to 1 000 μg·L-1.The intra-day and inter-day RSD was less than 10%.The main pharmacokinetic parameters of the test and reference azithromycin tablets were as follows: Cmax(594.9±195.7) vs.(586.3±186.5) μg·L-1;Tmax(2.02±0.91) vs.(1.70 ± 0.80) h;T1/2(29.20±8.38) vs.(27.28±7.62) h;AUC0~t(4 736±1 317) vs.(4 567±1 129) μg·h·L-1.The relative bioavalability of test tablets was(104.0±14.6) %.Conclusion: HPLC-MS method established in this study is simpler and more sensitive with better accuracy,which is adapted to study azithromycin pharmacokinetics.The two preparations of azithromycin are bioequivalent.
Key concepts: Azithromycin, Pharmacokinetics, Bioequivalence, Cmax, Crossover study, High-performance liquid chromatography, Pharmacology, Medicine